Mitochondria-dependent apoptosis in T-cell homeostasis

Current Opinion in Investigational Drugs

Volumn 6, Issue 11, 2005, Pages 1095-1102

  Grimaldi, Marina ^a   Denizot, Mélanie ^a   Espert, Lucile ^a   Robert Hebmann, Véronique ^a   Biard Piechaczyk, Martine ^a  

^a CNRS   (France)

Author keywords

Apoptosis; Autoimmunity; Cancer; Immunodeficiency; Mitochondria; T cell

Indexed keywords

ANTIBIOTIC AGENT; ANTIMALARIAL AGENT; ANTIRETROVIRUS AGENT; ANTISENSE OLIGONUCLEOTIDE; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; ARSENIC TRIOXIDE; BENZODIAZEPINE DERIVATIVE; BETULIC ACID; BH3 PROTEIN; BORTEZOMIB; CAPSAICIN; CASPASE 9; CYTOCHROME C; DOXORUBICIN; FANSIDAR; FENTANYL; GADOLINIUM TEXAPHYRIN; IMATINIB; NUCLEOSIDE ANALOG; PROTEASOME INHIBITOR; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; PROTEIN KINASE C INHIBITOR; PROTEIN P53; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SURVIVIN; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG;

APOPTOSIS; AUTOIMMUNITY; BONE MARROW CELL; CANCER; CELL MATURATION; CELL SELECTION; CELL SURVIVAL; CHRONIC MYELOID LEUKEMIA; DRUG MECHANISM; DRUG TARGETING; HEMATOLOGIC MALIGNANCY; HOMEOSTASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; IMMUNE SYSTEM; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; LYMPHOCYTE PROLIFERATION; MALARIA; MITOCHONDRION; NONHUMAN; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; REVIEW; T LYMPHOCYTE; THYMUS;

ANIMALS; ANTIVIRAL AGENTS; APOPTOSIS; AUTOIMMUNE DISEASES; CLONAL DELETION; HIV INFECTIONS; HOMEOSTASIS; HUMANS; IMMUNOTHERAPY, ACTIVE; LEUKEMIA; LYMPHOCYTE ACTIVATION; MITOCHONDRIA; PIPERAZINES; PROTEIN KINASE INHIBITORS; PYRIMIDINES; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; THYMUS GLAND;

EID: 28244478435     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Philchenkov A: Caspases: Potential targets for regulating cell death. J Cell Mol Med (2004) 8(4):432-444.
2. Riedl SJ, Shi Y: Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol (2004) 5(11):897-907.
3. Thorburn A: Death receptor-induced cell killing. Cell Signal (2004) 16(2):139-144.
4. 2+- and redox-dependent production of nitric oxide. J Immunol (2003) 171(10):5188-5197.
5. Haupt S, Berger M, Goldberg Z, Haupt Y: Apoptosis - the p53 network. J Cell Sci (2003) 116(20):4077-4085.
6. Green DR: Overview: Apoptotic signaling pathways in the immune system. Immunol Rev (2003) 193:5-9.
7. de Graaf AO, de Witte T, Jansen JH: Inhibitor of apoptosis proteins: New therapeutic targets in hematological cancer? Leukemia (2004) 18(11):1751-1759.
8. Schimmer AD: Inhibitor of apoptosis proteins: Translating basic knowledge into clinical practice. Cancer Res (2004) 64(20):7183-7190.
9. Conte D, Liston P, Wong JW, Wright KE, Korneluk RG: Thymocyte-targeted overexpression of XIAP transgene disrupts T lymphoid apoptosis and maturation. Proc Natl Acad Sci USA (2001) 98(9):5049-5054.
10. Xing Z, Conway EM, Kang C, Winoto A: Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis. J Exp Med (2004) 199(1):69-80.
11. Uren AG, Wong L, Pakusch M, Fowler KJ, Burrows FJ, Vaux DL, Choo KH: Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol (2000) 10(21):1319-1328.
12. Hildeman DA, Zhu Y, Mitchell TC, Kappler J, Marrack P: Molecular mechanisms of activated T cell death in vivo. Curr Opin Immunol (2002) 14(3):354-359.
13. Green DR: Introduction: Apoptosis in the development and function of the immune system. Semin Immunol (2003) 15(3):121-123.
14. Marsden VS, Strasser A: Control of apoptosis in the immune system: Bcl-2, BH3-only proteins and more. Annu Rev Immunol (2003) 21:71-105.
15. Sohn SJ, Rajpal A, Winoto A: Apoptosis during lymphoid development. Curr Opin Immunol (2003) 15(2):209-216.
16. Strasser A, Bouillet P: The control of apoptosis in lymphocyte selection. Immunol Rev (2003) 193:82-92.
17. Mandal M, Borowski C, Palomero T, Ferrando AA, Oberdoerffer P, Meng F, Ruiz-Vela A, Ciofani M, Zuniga-Pflucker JC, Screpanti I, Look AT et al: The BCL2A1 gene as a pre-T cell receptor-induced regulator of thymocyte survival. J Exp Med (2005) 201(4):603-614.
18. Bouillet P, Purton JF, Godfrey DI, Zhang LC, Coultas L, Puthalakath H, Pellegrini M, Cory S, Adams JM, Strasser A: BH3-only Bcl-2 family member Bim is required for apoptosis of autoreactive thymocytes. Nature (2002) 415(6874):922-926.
19. Rathmell JC, Lindsten T, Zong WX, Cinalli RM, Thompson CB: Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol (2002) 3(10):932-939.
20. Hildeman DA, Zhu Y, Mitchell TC, Bouillet P, Strasser A, Kappler J, Marrack P: Activated T cell death in vivo mediated by proapoptotic Bcl-2 family member Bim. Immunity (2002) 16(6):759-767.
21. Tripathi P, Hildeman D: Sensitization of T cells to apoptosis - a role for ROS? Apoptosis (2004) 9(5):515-523.
22. Hildeman DA: Regulation of T-cell apoptosis by reactive oxygen species. Free Radic Biol Med (2004) 36(12):1496-1504.
23. Capdeville R, Buchdunger E, Zimmermann J, Matter A: Glivec (STI571, imatinib), a rationally developed, targeted anticancer drug. Nat Rev Drug Discov (2002) 1(7):493-502.
24. Hei TK, Liu SX, Waldren C: Mutagenicity of arsenic in mammalian cells: Role of reactive oxygen species. Proc Natl Acad Sci USA (1998) 95(14):8103-8107.
25. Ahr B, Robert-Hebmann V, Devaux C, Biard-Piechaczyk M: Apoptosis of uninfected cells induced by HIV envelope glycoproteins. Retrovirology (2004) 1(1):12.
26. Boya P, Pauleau AL, Poncet D, Gonzalez-Polo RA, Zamzami N, Kroemer G: Viral proteins targeting mitochondria: Controlling cell death. Biochim Biophys Acta (2004) 1659(2-3):178-189.
27. Perfettini JL, Castedo M, Roumier T, Andreau K, Nardacci R, Piacentini M, Kroemer G: Mechanisms of apoptosis induction by the HIV-1 envelope. Cell Death Differ (2005) 12(Suppl 1):916-923.
28. Phenix BN, Badley AD: Influence of mitochondrial control of apoptosis on the pathogenesis, complications and treatment of HIV infection. Biochimie (2002) 84(2-3):251-264.
29. Cereseto A, Kislyakova T, Washington Parks R, Nicot C, Franchini G: Differential response to genotoxic stress in immortalized or transformed human T-lymphotropic virus type I-infected T-cells. J Gen Virol (1999) 80(7):1575-1581.
30. Mahieux R, Pise-Masison C, Gessain A, Brady JN, Olivier R, Perret E, Misteli T, Nicot C: Arsenic trioxide induces apoptosis in human T-cell leukemia virus type 1- and type 2-infected cells by a caspase-3-dependent mechanism involving Bcl-2 cleavage. Blood (2001) 98(13):3762-3769.
31. Crispin JC, Vargas MI, Alcocer-Varela J: Immunoregulatory T cells in autoimmunity. Autoimmun Rev (2004) 3(2):45-51.
32. Bluestone JA, Tang Q: Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells. Proc Natl Acad Sci USA (2004) 101(Suppl 2):14622-14626.
33. Horwitz DA, Zheng SG, Gray JD, Wang JH, Ohtsuka K, Yamagiwa S: Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin Immunol (2004) 16(2):135-143.
34. Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W, Reed JC: Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes. Cancer Res (1993) 53(19):4701-4714.
35. Hsu YT, Youle RJ: Nonionic detergents induce dimerization among members of the Bcl-2 family. J Biol Chem (1997) 272(21):13829-13834.
36. O'Reilly LA, Print C, Hausmann G, Moriishi K, Cory S, Huang DC, Strasser A: Tissue expression and subcellular localization of the pro-survival molecule Bcl-w. Cell Death Differ (2001) 8(5):486-494.
37. Yang T, Kozopas KM, Craig RW: The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J Cell Biol (1995) 128(6):1173-1184.
38. Somogyi RD, Wu Y, Orlofsky A, Prystowsky MB: Transient expression of the Bcl-2 family member, A1-a, results in nuclear localization and resistance to staurosporine-induced apoptosis. Cell Death Differ (2001) 8(8):785-793.
39. Song Q, Kuang Y, Dixit VM, Vincenz C: Boo, a novel negative regulator of call death, interacts with Apaf-1. EMBO J (1999) 18(1):167-178.
40. Nakayama K, Nakayama K, Negishi I, Kuida K, Shinkai Y, Louie MC, Fields LE, Lucas PJ, Stewart V, Alt FW et al: Disappearance of the lymphoid system in Bcl-2 homozygous mutant chimeric mice. Science (1993) 261(5128):1584-1588.
41. Motoyama N, Wang F, Roth KA, Sawa H, Nakayama K, Nakayama K, Negishi I, Senju S, Zhang Q, Fujii S et al: Massive cell death of immature hematopoietic cells and neurons in Bcl-x-deficient mice. Science (1995) 267(5203):1506-1510.
42. Print CG, Loveland KL, Gibson L, Meehan T, Stylianou A, Wreford N, de Kretser D, Metcalf D, Kontgen F, Adams JM, Cory S: Apoptosis regulator Bcl-w is essential for spermatogenesis but appears otherwise redundant. Proc Natl Acad Sci USA (1998) 95(1):12424-12431.
43. Rinkenberger JL, Horning S, Klocke B, Roth K, Korsmeyer SJ: Mcl-1 deficiency results in peri-implantation embryonic lethality. Genes Dev (2000) 14(1):23-27.
44. Hamasaki A, Sendo F, Nakayama K, Nakayama K, Ishida N, Negishi I, Hatakeyama S: Accelerated neutrophil apoptosis in mice lacking A1-a, a subtype of the bcl-2-related A1 gene. J Exp Med (1998) 188(11):1985-1992.
45. Russell HR, Lee Y, Miller HL, Zhao J, McKinnon PJ: Murine ovarian development is not affected by inactivation of the Bcl-2 family member diva. Mol Cell Biol (2002) 22(19):6866-6870.
46. 2+: A control point for apoptosis. Science (2003) 300(5616):135-139.
47. L in cardiomyocytes. J Mol Cell Cardiol (2005) 38(3):485-493.
48. S and Bax induce different apoptotic pathways in PC12 cells. Oncogene (2000) 19(14):1783-1793.
49. Coultas L, Pellegrini M, Visvader JE, Lindeman GJ, Chen L, Adams JM, Huang DC, Strasser A: Bfk: A novel weakly proapoptotic member of the Bcl-2 protein family with a BH3 and a BH2 region. Cell Death Differ (2003) 10(2):185-192.
50. Kataoka T, Holler N, Micheau O, Martinon F, Tinel A, Hofmann K, Tschopp J: Bcl-rambo, a novel Bcl-2 homologue that induces apoptosis via its unique C-terminal extension. J Biol Chem (2001) 276(22):19548-19554.
51. Knudson CM, Tung KS, Tourtellotte WG, Brown GA, Korsmeyer SJ: Bax-deficient mice with lymphoid hyperplasia and male germ cell death. Science (1995) 270(5233):96-99.
52. Lindsten T, Ross AJ, King A, Zong WX, Rathmell JC, Shiels HA, Ulrich E, Waymire KG, Mahar P, Frauwirth K, Chen Y et al: The combined functions of proapoptotic Bcl-2 family members Bak and Bax are essential for normal development of multiple tissues. Mol Cell (2000) 6(6):1389-1399.
53. L. Cell (1996) 87(4):619-628.
54. Wang K, Yin XM, Chao DT, Milliman CL, Korsmeyer SJ: Bid: A novel BH3 domain-only death agonist. Genes Dev (1996) 10(22):2859-2869.
55. Germain M, Mathai JP, Shore GC: BH-3-only Bik functions at the endoplasmic reticulum to stimulate cytochrome C release from mitochondria. J Biol Chem (2002) 277(20):18053-18060.
56. Puthalakath H, Huang DC, O'Reilly LA, King SM, Strasser A: The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. Mol Cell (1999) 3(3):287-296.
57. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N: Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science (2000) 288(5468):1053-1058.
58. L and induces cell death independent of a Bcl-2 homology 3 (BH3) domain at both mitochondrial and nonmitochondrial sites. J Biol Chem (2000) 275(2):1439-1448.
59. Webster KA, Graham RM, Bishopric NH: BNip3 and signal-specific programmed death in the heart. J Mol Cell Cardiol (2005) 38(1):35-45.
60. Puthalakath H, Villunger A, O'Reilly LA, Beaumont JG, Coultas L, Cheney RE, Huang DC, Strasser A: Bmf: A proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science (2001) 293(5536):1829-1832.
61. Ranger AM, Zha J, Harada H, Datta SR, Danial NN, Gilmore AP, Kutok JL, Le Beau MM, Greenberg ME, Korsmeyer SJ: Bad-deficient mice develop diffuse large B cell lymphoma. Proc Natl Acad Sci USA (2003) 100(16):9324-9329.
62. Zinkel SS, Ong CC, Ferguson DO, Iwasaki H, Akashi K, Bronson RT, Kutok JL, Alt FW, Korsmeyer SJ: Proapoptotic Bid is required for myeloid homeostasis and tumor suppression. Genes Dev (2003) 17(2):229-239.
63. Coultas L, Bouillet P, Stanley EG, Brodnicki TC, Adams JM, Strasser A: Proapoptotic BH3-only Bcl-2 family member Bik/Blk/Nbk is expressed in hemopoietic and endothelial cells but is redundant for their programmed death. Mol Cell Biol (2004) 24(4):1570-1581.
64. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM, Strasser A: Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science (1999) 286(5445):1735-1738.
65. Shibue T, Takeda K, Oda E, Tanaka H, Murasawa H, Takaoka A, Morishita Y, Akira S, Taniguchi T, Tanaka N: Integral role of Noxa in p53-mediated apoptotic response. Genes Dev (2003) 17(18):2233-2238.
66. Villunger A, Scott C, Bouillet P, Strasser A: Essential role for the BH3-only protein Bim but redundant roles for Bax, Bcl-2, and Bcl-w in the control of granulocyte survival. Blood (2003) 101(6):2393-2400.
67. Shangary S, Johnson DE: Recent advances in the development of anticancer agents targeting cell death inhibitors in the Bcl-2 protein family. Leukemia (2003) 17(8):1470-1481.
68. Manion MK, Hockenbery DM: Targeting Bcl-2-related proteins in cancer therapy. Cancer Biol Ther (2003) 2(4 Suppl 1):S105-S114.
69. Brady HJ: Apoptosis and leukaemia. Br J Haematol (2003) 123(4):577-585.
70. Hersey P, Zhang XD: Overcoming resistance of cancer cells to apoptosis. J Cell Physiol (2003) 196(1):9-18.
71. Walensky LD, Kung AL, Escher I, Malia TJ, Barbuto S, Wright RD, Wagner G, Verdine GL, Korsmeyer SJ: Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science (2004) 305(5689):1466-1470.
72. Juin P, Geneste O, Raimbaud E, Hickman JA: Shooting at survivors: Bcl-2 family members as drug targets for cancer. Biochim Biophys Acta (2004) 1644(2-3):251-260.
73. Lickliter JD, Wood NJ, Johnson L, McHugh G, Tan J, Wood F, Cox J, Wickham NW: HA14-1 selectively induces apoptosis in Bcl-2-overexpressing leukemia/lymphoma cells, and enhances cytarabine-induced cell death. Leukemia (2003) 17(11):2074-2080.
74. Chen J, Freeman A, Liu J, Dai Q, Lee RM: The apoptotic effect of HA14-1, a Bcl-2-interacting small molecular compound, requires Bax translocation and is enhanced by PK11195. Mol Cancer Ther (2002) 1(12):961-967.
75. Snowden RT, Sun XM, Dyer MJ, Cohen GM: Bisindolylmaleimide IX is a potent inducer of apoptosis in chronic lymphocytic leukaemic cells and activates cleavage of Mcl-1. Leukemia (2003) 17(10):1981-1989.
76. Evens AM: Motexafin gadolinium: A redox-active tumor selective agent for the treatment of cancer. Curr Opin Oncol (2004) 16(6):576-580.
77. Evens AM, Lecane P, Magda D, Prachand S, Singhal S, Nelson J, Miller RA, Gartenhaus RB, Gordon LI: Motexafin gadolinium generates reactive oxygen species and induces apoptosis in sensitive and highly resistant multiple myeloma cells. Blood (2005) 105(3):1265-1273.
78. Huang HL, Chen CC, Yeh CY, Huang RL: Reactive oxygen species mediation of baizhu-induced apoptosis in human leukemia cells. J Ethnopharmacol (2005) 97(1):21-29.
79. Delogu G, Moretti S, Antonucci A, Marandola M, Tellan G, Sale P, Carnevali R, Famularo G: Apoptogenic effect of fentanyl on freshly isolated peripheral blood lymphocytes. J Trauma (2004) 57(1):75-81.
80. Ito K, Nakazato T, Yamato K, Miyakawa Y, Yamada T, Hozumi N, Segawa K, Ikeda Y, Kizaki M: Induction of apoptosis in leukemic cells by homovanillic acid derivative, capsaicin, through oxidative stress: Implication of phosphorylation of p53 at Ser-15 residue by reactive oxygen species. Cancer Res (2004) 64(3):1071-1078.
81. Belka C, Jendrossek V, Pruschy M, Vink S, Verheij M, Budach W: Apoptosis-modulating agents in combination with radiotherapy-current status and outlook. Int J Radiat Oncol Biol Phys (2004) 58(2):542-554.
82. Ehrhardt H, Fulda S, Fuhrer M, Debatin KM, Jeremias I: Betulinic acid-induced apoptosis in leukemia cells. Leukemia (2004) 18(8):1406-1412.
83. Subhashini J, Mahipal SV, Reddy MC, Mallikarjuna Reddy M, Rachamallu A, Reddanna P: Molecular mechanisms in C-Phycocyanin induced apoptosis in human chronic myeloid leukemia cell line-K562. Biochem Pharmacol (2004) 68(3):453-462.
84. Reddy MC, Subhashini J, Mahipal SV, Bhat VB, Srinivas Reddy P, Kiranmai G, Madyastha KM, Reddanna P: C-Phycocyanin, a selective cyclooxygenase-2 inhibitor, induces apoptosis in lipopolysaccharide-stimulated RAW 264.7 macrophages. Biochem Biophys Res Commun (2003) 304(2):385-392.
85. Schmelz K, Wieder T, Tamm I, Muller A, Essmann F, Geilen CC, Schulze-Osthoff K, Dorken B, Daniel PT: Tumor necrosis factor α sensitizes malignant cells to chemotherapeutic drugs via the mitochondrial apoptosis pathway independently of caspase-8 and NF-κB. Oncogene (2004) 23(40):6743-6759.
86. Pahler JC, Ruiz S, Niemer I, Calvert LR, Andreeff M, Keating M, Faderl S, McConkey DJ: Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia. Clin Cancer Res (2003) 9(12):4570-4577.
87. Tinhofer I, Anether G, Senfter M, Pfaller K, Bernhard D, Hara M, Greil R: Stressful death of T-ALL tumor cells after treatment with the antitumor agent Tetrocarcin-A. FASEB J (2002) 16(10):1295-1297.
88. Prokop A, Wrasidlo W, Lode H, Herold R, Lang F, Henze G, Dorken B, Wieder T, Daniel PT: Induction of apoptosis by enediyne antibiotic calicheamicin thetall proceeds through a caspase-mediated mitochondrial amplification loop in an entirely Bax-dependent manner. Oncogene (2003) 22(57):9107-9120.
89. Bustamante J, Caldas Lopes E, Garcia M, Di Libero E, Alvarez E, Hajos SE: Disruption of mitochondrial membrane potential during apoptosis induced by PSC 833 and CsA in multidrug-resistant lymphoid leukemia. Toxicol Appl Pharmacol (2004) 199(1):44-51.
90. Phenix BN, Angel JB, Mandy F, Kravcik S, Parato K, Chambers KA, Gallicano K, Hawley-Foss N, Cassol S, Cameron DW, Badley AD: Decreased HIV-associated T cell apoptosis by HIV protease inhibitors. AIDS Res Hum Retroviruses (2000) 16(6):559-567.
91. Matarrese P, Gambardella L, Cassone A, Vella S, Cauda R, Malorni W: Mitochondrial membrane hyperpolarization hijacks activated T lymphocytes toward the apoptotic-prone phenotype: Homeostatic mechanisms of HIV protease inhibitors. J Immunol (2003) 170(12):6006-6015.
92. Blatt NB, Bednarski JJ, Warner RE, Leonetti F, Johnson KM, Boitano A, Yung R, Richardson BC, Johnson KJ, Ellman JA, Opipari AW Jr, Glick GD: Benzodiazepine-induced superoxide signals B cell apoptosis: Mechanistic insight and potential therapeutic utility. J Clin Invest (2002) 110(8):1123-1132.